Pliant Therapeutics said it released third-quarter 2026 financial results and a company update, though no figures were disclosed in the source. The update comes

Pliant Therapeutics said it released third-quarter 2026 financial results and a company update, though no figures were disclosed in the source. The update comes as Pliant expands RNAi capabilities and prepares new PLN-101095 data for SITC 2026.